CHSY3 can be a Poor Prognostic Biomarker and Mediates Immune Evasion in Stomach Adenocarcinoma

Background: Chondroitin sulphate synthase 3 (CHSY3) is an important enzyme that regulates glycosylation, but it has not been reported in tumours. This study explored for the first time the oncological features of CHSY3 in stomach adenocarcinoma (STAD). Methods: We analysed CHSY3 expression in STAD t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinwei, Fan, Yongfei, Zhang, Yue, Wang, Yanyan, Zhao, Menglin, Tang, Mingyue, Li, Huiyuan, Mi, Jiaqi, Geng, Zhijun, Wang, Zishu, Su, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093181/
https://www.ncbi.nlm.nih.gov/pubmed/35571047
http://dx.doi.org/10.3389/fgene.2022.876588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093181/
https://www.ncbi.nlm.nih.gov/pubmed/35571047
http://dx.doi.org/10.3389/fgene.2022.876588

Ejemplares similares